About Index Trending news
Analyze
Top 50 Pricing
MISSION Therapeutics

MISSION Therapeutics

Work at MISSION Therapeutics? Add yourself to this profile

MISSION Therapeutics

MISSION Therapeutics is a novel biotech company developing small molecule drugs that target deubiquitylating enzymes (DUBs) involved in the DNA damage response

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series C)
£60,000,000
Grant
$2,895,017
Employees

Team size

10+
Locations
HQ
£60,000,000 Venture capital (Series C)
FinSMEs

Mission Therapeutics Raises £60M in Funding

Funding Health Science